1. Home
  2. CHY vs QDEL Comparison

CHY vs QDEL Comparison

Compare CHY & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Convertible and High Income Fund

CHY

Calamos Convertible and High Income Fund

N/A

Current Price

$10.61

Market Cap

960.4M

Sector

Finance

ML Signal

N/A

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

N/A

Current Price

$10.73

Market Cap

989.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHY
QDEL
Founded
2003
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.4M
989.5M
IPO Year
2003
2022

Fundamental Metrics

Financial Performance
Metric
CHY
QDEL
Price
$10.61
$10.73
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
201.8K
★ 2.2M
Earning Date
01-01-0001
11-03-2026
Dividend Yield
★ 10.11%
N/A
EPS Growth
N/A
★ 45.35
EPS
★ N/A
N/A
Revenue
N/A
★ $2,730,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.41
$9.92
52 Week High
$13.91
$35.58

Technical Indicators

Market Signals
Indicator
CHY
QDEL
Relative Strength Index (RSI) 35.06 37.87
Support Level $10.41 $10.49
Resistance Level $12.21 $18.15
Average True Range (ATR) 0.22 1.25
MACD 0.01 -0.37
Stochastic Oscillator 5.95 7.55

Price Performance

Historical Comparison
CHY
QDEL

About CHY Calamos Convertible and High Income Fund

Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Share on Social Networks: